HENDERA
831152
Hengerda New Materials
300946
Fujian Nebula Electronics.,Ltd
300648
Cubic Digital Technology
300344
HNAC Technology
300490
CN Stock MarketDetailed Quotes
688212 Shanghai Aohua Photoelectricity Endoscope
- 42.35
- -1.67-3.79%
Market Closed Feb 18 15:00 CST
5.70BMarket Cap114.15P/E (TTM)
44.40High42.16Low12.02KlotVolume43.72Open44.02Pre Close51.68MTurnover0.89%Turnover Ratio98.49P/E (Static)134.59MShares66.2252wk High4.12P/B5.70BFloat Cap31.5152wk Low52.82Limit Up134.59MShs Float83.70Historical High35.22Limit Down5.09%Amplitude31.51Historical Low0.30Dividend TTM42.99Avg Price7.38KlotAsk0.71%Div YieldTTM100Lot Size4.08KlotBid
Shanghai Aohua Photoelectricity Endoscope Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 16.79%500.55M | 22.29%353.52M | 34.91%169.3M | 52.29%678.08M | 52.65%428.59M | 72.74%289.08M | 53.77%125.49M | 28.30%445.26M | 22.55%280.77M | 13.92%167.35M |
| Operating revenue | 16.79%500.55M | 22.29%353.52M | 34.91%169.3M | 52.29%678.08M | 52.65%428.59M | 72.74%289.08M | 53.77%125.49M | 28.30%445.26M | 22.55%280.77M | 13.92%167.35M |
| Total operating cost | 18.95%504.92M | 33.78%371.84M | 46.01%176.93M | 46.45%651.78M | 53.56%424.47M | 65.51%277.96M | 54.65%121.18M | 46.31%445.06M | 35.32%276.42M | 22.59%167.94M |
| Operating cost | 17.84%153.91M | 21.93%100.91M | 33.57%39.95M | 31.87%177.77M | 52.72%130.61M | 71.00%82.76M | 19.60%29.91M | 26.46%134.8M | 25.57%85.52M | 6.92%48.39M |
| Operating tax surcharges | -6.84%4.02M | -6.23%2.69M | 23.44%1.53M | 71.16%6.42M | 85.12%4.31M | 92.13%2.86M | 25.96%1.24M | 25.70%3.75M | -2.56%2.33M | 3.30%1.49M |
| Operating expense | 25.35%159.51M | 44.93%122.62M | 53.11%63.58M | 76.29%232.37M | 64.15%127.25M | 75.93%84.61M | 93.80%41.52M | 80.68%131.81M | 58.05%77.52M | 49.40%48.09M |
| Administration expense | 28.24%74.78M | 45.89%58.68M | 63.71%27.76M | 7.73%90.87M | -6.99%58.31M | -0.77%40.22M | -8.73%16.95M | 19.80%84.35M | 28.30%62.69M | 18.67%40.54M |
| Financial expense | 81.05%-397.47K | 81.25%-392.79K | -24.53%-355.85K | 57.46%-2.63M | 81.15%-2.1M | 72.02%-2.09M | 84.50%-285.74K | -425.26%-6.19M | -1,862.29%-11.13M | -1,407.63%-7.49M |
| -Interest expense (Financial expense) | 71.80%945.04K | -12.97%332.42K | -31.71%134.15K | 10.31%695.1K | 20.86%550.09K | 27.69%381.97K | 115.97%196.43K | 103.25%630.15K | 161.86%455.15K | 60.77%299.13K |
| -Interest Income (Financial expense) | 20.36%-1.81M | 48.11%-776.65K | 13.01%-577K | 52.62%-2.98M | 79.81%-2.27M | 80.89%-1.5M | 69.98%-663.31K | -503.60%-6.28M | -1,675.49%-11.26M | -1,424.06%-7.83M |
| Research and development | 6.62%113.11M | 25.48%87.34M | 39.70%44.48M | 52.26%147M | 78.31%106.09M | 88.54%69.6M | 124.04%31.84M | 95.62%96.54M | 68.85%59.5M | 57.99%36.92M |
| Credit Impairment Loss | -76.14%-9.96M | -110.64%-7.56M | -553.11%-4.79M | -67.20%-7.85M | -136.40%-5.65M | -220.86%-3.59M | -767.33%-733.55K | -45.97%-4.69M | -26.74%-2.39M | 28.71%-1.12M |
| Asset Impairment Loss | 0.93%-4.2M | 33.04%-2.79M | -13.09%-2.04M | -179.34%-18.02M | -63.05%-4.24M | -343.72%-4.16M | -19.77%-1.8M | -58.40%-6.45M | 47.11%-2.6M | 66.26%-937.56K |
| Other net revenue | ||||||||||
| Fair value change income | -21.92%4.6M | -5.41%3.93M | -8.30%2.15M | 1.99%7.91M | 770.63%5.9M | 298.85%4.16M | 181.00%2.35M | 23,228.85%7.75M | 973.19%677.4K | 13,374.80%1.04M |
| Invest income | 16.07%3.95M | -4.87%2.61M | 11.34%1.24M | -40.44%3.64M | -20.59%3.41M | 1.46%2.75M | 34.41%1.11M | 569.95%6.11M | 914.75%4.29M | 1,602.40%2.71M |
| -Including: Investment income associates | -83.91%127.44K | -121.84%-125.57K | -151.07%-44.25K | -22.11%745.06K | -42.34%792.14K | -21.30%574.83K | 112.29%86.64K | 198.87%956.57K | 811.73%1.37M | 954.50%730.41K |
| Asset deal income | 120.77%155.59K | 132.08%150.88K | 106.41%31.18K | -640.58%-749.1K | -820.33%-749.1K | -1,060.48%-470.4K | -1,100.42%-486.58K | -64.37%138.57K | -133.45%-81.4K | -116.66%-40.53K |
| Other revenue | 12.18%40.38M | -23.22%19.88M | 1.61%10.72M | 418.41%43.11M | 2,054.85%36M | 2,087.12%25.89M | 1,602.23%10.55M | -60.13%8.32M | -81.43%1.67M | -81.62%1.18M |
| Operating profit | -21.19%30.57M | -105.88%-2.1M | -102.06%-315.67K | 378.11%54.34M | 555.86%38.79M | 1,491.19%35.7M | 291.83%15.3M | -80.33%11.37M | -78.70%5.91M | -81.93%2.24M |
| Add:Non operating Income | -63.69%4.32K | -65.47%4.11K | -92.71%643.07 | -99.93%3.99K | -96.42%11.91K | -96.40%11.91K | --8.82K | 7,875.23%5.87M | 569.65%332.25K | 568.09%331.2K |
| Less:Non operating expense | 70.95%484.23K | 5.74%294.86K | -99.74%700 | 71.98%433.3K | 667.22%283.26K | 655.22%278.85K | 830.55%272.09K | 89.39%251.95K | -57.35%36.92K | -53.75%36.92K |
| Total profit | -21.88%30.09M | -106.74%-2.39M | -102.10%-315.73K | 217.41%53.91M | 520.29%38.52M | 1,296.15%35.43M | 287.99%15.04M | -70.57%16.98M | -77.61%6.21M | -79.51%2.54M |
| Less:Income tax cost | 1.49%-6.87M | -243.44%-7.96M | -100.77%-2.87M | 14.91%-6.86M | -72.02%-6.97M | 25.19%-2.32M | -495.00%-1.43M | -290.88%-8.07M | -178.12%-4.05M | -250.66%-3.1M |
| Net profit | -18.75%36.96M | -85.24%5.57M | -84.49%2.55M | 142.60%60.77M | 343.22%45.49M | 569.77%37.75M | 368.60%16.47M | -58.09%25.05M | -54.46%10.26M | -45.42%5.64M |
| Net profit from continuing operation | -18.75%36.96M | -85.24%5.57M | -84.49%2.55M | 142.60%60.77M | 343.22%45.49M | 569.77%37.75M | 368.60%16.47M | -58.09%25.05M | -54.46%10.26M | -45.42%5.64M |
| Less:Minority Profit | -214.05%-344.68K | 73.10%-89.6K | -168.32%-205.63K | -13.79%2.92M | -82.03%302.22K | -158.61%-333.08K | -170.97%-76.64K | 23.80%3.39M | -5.99%1.68M | -51.06%568.31K |
| Net profit of parent company owners | -17.45%37.3M | -85.13%5.66M | -83.32%2.76M | 167.04%57.85M | 426.53%45.19M | 651.46%38.08M | 385.71%16.55M | -62.02%21.66M | -58.64%8.58M | -44.71%5.07M |
| Earning per share | ||||||||||
| Basic earning per share | -17.65%0.28 | -86.21%0.04 | -83.33%0.02 | 168.75%0.43 | 466.67%0.34 | 625.00%0.29 | 300.00%0.12 | -70.91%0.16 | -71.43%0.06 | -55.56%0.04 |
| Diluted earning per share | -17.65%0.28 | -85.71%0.04 | -83.33%0.02 | 168.75%0.43 | 466.67%0.34 | 600.00%0.28 | 300.00%0.12 | -70.91%0.16 | -71.43%0.06 | -55.56%0.04 |
| Other composite income | -120.17%-229.91K | -144.11%-1.41M | -362.27%-1.3M | 120.51%3.03M | 174.87%1.14M | 324.78%3.2M | 135.41%495.44K | 128.52%1.37M | -7.30%-1.52M | -4.70%-1.42M |
| Other composite income of parent company owners | -120.17%-229.91K | -144.11%-1.41M | -362.27%-1.3M | 120.51%3.03M | 174.87%1.14M | 324.78%3.2M | 135.41%495.44K | 128.52%1.37M | -7.30%-1.52M | -4.70%-1.42M |
| Total composite income | -21.23%36.73M | -89.83%4.16M | -92.61%1.25M | 141.45%63.8M | 433.45%46.63M | 871.65%40.94M | 701.90%16.97M | -51.92%26.42M | -58.61%8.74M | -53.01%4.21M |
| Total composite income of parent company owners | -19.97%37.07M | -89.70%4.25M | -91.43%1.46M | 164.27%60.88M | 556.22%46.33M | 1,032.26%41.28M | 748.84%17.04M | -55.89%23.04M | -63.48%7.06M | -53.30%3.65M |
| Total composite income of minority owners | -214.05%-344.68K | 73.10%-89.6K | -168.32%-205.63K | -13.79%2.92M | -82.03%302.22K | -158.61%-333.08K | -170.97%-76.64K | 23.80%3.39M | -5.99%1.68M | -51.06%568.31K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
